Details for New Drug Application (NDA): 020934
✉ Email this page to a colleague
The generic ingredient in LUXIQ is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 020934
Tradename: | LUXIQ |
Applicant: | Norvium Bioscience |
Ingredient: | betamethasone valerate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020934
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 0.12% | ||||
Approval Date: | Feb 28, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 020934
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Norvium Bioscience | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription